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Abstract
Previous studies have demonstrated that the c-aminobutyric acid type B (GABAB) receptor plays an essential role in
modulating neurotransmitter release and regulating the activity of ion channels and adenyl cyclase. However, whether the
naturally occurring polymorphisms in the two GABAB receptor subunit genes interact with each other to alter susceptibility
to nicotine dependence (ND) remains largely unknown. In this study, we genotyped 5 and 33 single nucleotide
polymorphisms (SNPs) for GABAB receptor subunit 1 and 2 genes (GABBR1, GABBR2), respectively, in a sample of 2037
individuals from 602 nuclear families of African- American (AA) or European-American (EA) origin. We conducted association
analyses to determine (1) the association of each subunit gene with ND at both the individual SNP and haplotype levels and
(2) the collective effect(s) of SNPs in both GABAB subunits on the development of ND. Several individual SNPs and
haplotypes in GABBR2 were significantly associated with ND in both ethnic samples. Two haplotypes in AAs and one
haplotype in EAs showed a protective effect against ND, whilst two other haplotypes in AAs and three haplotypes in EAs
showed a risk effect for developing ND. Interestingly, these significant haplotypes were confined to two regions of GABBR2
in the AA and EA samples. Additionally, we found two minor haplotypes in GABBR1 to be positively associated with
Heaviness of Smoking Index (HSI) in the EA sample. Finally, we demonstrated the presence of epistasis between GABBR1 and
GABBR2 for developing ND. The variants of GABBR1 and GABBR2 are significantly associated with ND, and the involvement of
GABBR1 is most likely through its interaction with GABBR2, whereas GABBR2 polymorphisms directly alter susceptibility to
ND. Future studies are needed with more dense SNP coverage of GABBR1 and GABBR2 to verify the epistatic effects of the
two subunit genes.
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Introduction
Tobacco smoking is a serious public health concern worldwide,
as nearly a third of adults smoke tobacco or related products [1].
Nicotine is the main psychoactive substance in cigarettes that
functions as a reward and maintains its continued use, ultimately
leading to dependence [1]. Meta-analysis of twin and family
studies reveals genetic susceptibility to nicotine dependence (ND),
with an average heritability of 0.56 [2]. ND also is influenced by
environmental factors, as well as by interaction between genetic
and environmental factors [2,3].
Substantial efforts have been geared toward identifying genes
that predispose individuals to become nicotine dependent.
Genome-wide linkage scans of various smoking phenotypes have
revealed several regions that likely harbor susceptibility loci for
ND [4,5], particularly on chromosomes 9, 10, 11, and 17 [4]. Of
these reproducibly identified regions, that on chromosome 9 is of
particular interest [6,7,8,9,10]. The first gene identified from this
linkage region was GABBR2 (G-protein coupled receptor 51), for
which several SNPs were found to be significantly associated with
ND in the Mid-South Tobacco Family (MSTF) cohort [11]. Since
that initial report, continued recruitment has yielded approxi-
mately a two-fold increase in the sample size of this cohort [10,12].
GABA is the main inhibitory neurotransmitter in the central
nervous system, whose actions are mediated by both ionotropic
GABAA receptors and metabotropic GABAB receptors. GABAB
receptors are seven transmembrane G-protein-coupled proteins
that are pharmacologically functional only as a heterodimer
consisting of both GABAB1 and GABAB2 subunits [13]. GABA
neurons are part of the mesolimbic dopamine system, critically
important in mediating the reinforcing properties of drugs of
abuse. GABAB receptors, in particular, are responsible for
dampening the reinforcing effects of dopamine resulting from
natural reward. Additionally, the GABA system is diffusely
expressed in the brain; therefore, areas other than the mesolimbic
system may be partly responsible for these effects. Evidence exists
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7055from both animal and human studies supporting the value of
GABAB receptor agonists in the treatment of drug abuse.
Specifically, in preclinical studies, baclofen, a GABAB agonist,
has been successful in promoting abstinence and decreasing the
use of several drugs of abuse, including nicotine [14]. Baclofen also
has been effective in reducing cigarette smoking [15] and has been
reported to alter the sensory properties of cigarettes, reducing their
desirability [15].
A recent animal study examined the effect of nicotine on
GABBR2 expression in various brain regions in a rodent model
[16]. After chronic nicotine administration, GABBR2 mRNA was
significantly regulated in several brain regions generally associated
with addiction, thus providing further evidence that the GABA
system is involved in addictive processes. In the mammalian brain,
GABA is a major inhibitory neurotransmitter whose modulatory
actions are mediated through two types of receptors: the
ionotropic GABAA and the metabotropic GABAB [13]. GABAA
receptors form ion channels, whereas GABAB receptors activate
second-messenger systems thorough G-protein binding and
activation. GABAB receptors have two subunits, GABAB1 and
GABAB2, which must form a heterodimer to be pharmacologically
active [17]. Thus, the genes that encode these receptor subunits
were of particular interest in the current study.
On the basis of previous human and animal studies suggesting
that GABBR2 is involved in the etiology of ND, the current study
examined 33 SNPs in GABBR2 in a larger cohort of the MSTF
sample. Because the GABAB2 subunit protein does not bind with
the neurotransmitter GABA, it must form a heterodimer with the
GABA-binding GABAB1 subunit [13]; thus, we also examined the
association of five SNPs in GABBR1 with ND.
We found that several SNPs and haplotypes of GABBR2 were
significantly associated with ND in both European-American (EA)
and African-American (AA) samples. Although we found no
evidence for significant associations of GABBR1 with ND in either
ethnic sample, we detected a significant gene-gene interactive
(epistatic) effect between the two subunits by using a newly
developed pedigree-based generalized multifactor dimensionality
reduction (PGMDR) approach.
Materials and Methods
Ethics Statement
Informed written consent was obtained in advance from all
participants. The study was approved by the Institutional Review
Boards of University of Virginia and University of Mississippi
Medical Center and was in accordance with the principles of the
Helsinki Declaration II.
Study Participants
The AA and EA participants were recruited from the US Mid-
South States during 1999–2004 [10,12,18]. Detailed information
on the clinical characteristics of the samples is given in Table 1 and
in previous publications from this group [10,12,18,19]. Proband
smokers were required to be at least 21 years old, to have smoked
for at least the last five years, and to have consumed at least 20
cigarettes per day for the preceding 12 months. After a smoker
proband was identified, we attempted to recruit the biological
parents and all full siblings. A total of 2037 participants were
included in the current study, with 1366 individuals from 402 AA
families and 671 individuals from 200 EA families. The average
family size (6 standard deviation; SD) was 3.1460.75 for AAs and
3.1760.69 for EAs. The average age was 39.4614.4 years for AAs
and 40.5615.5 years for EAs. The ND of probands and other
smoker participants was assessed with the three measures
commonly used in the tobacco research field: Smoking Quantity
(SQ; number of cigarettes smoked per day), the Heaviness of
Smoking Index (HSI; 0–6 scale), and the Fagerstro ¨m Test for
Nicotine Dependence score (FTND; 0–10 scale) as a continuous
variable. Given the overlap in the content of the three ND
measures, there exist fairly robust correlations among them
(r=0.88–0.94) in both the AA and EA samples.
SNP Selection and Genotyping
A venous blood specimen was obtained from each participant,
and genomic DNA was extracted using a Qiagen Maxi kit (Qiagen
Inc, Valencia, CA). Five and thirty-three SNPs were selected from
the NCBI database (http://www.ncbi.nlm.nih.gov/projects/
SNP/; build 128) for the long isoform of GABBR1 and GABBR2,
respectively. The SNPs selected in GABBR2 were intended to
provide more uniform coverage with less redundancy of those
SNPs genotyped in our previous study [11]. Of the 33 SNPs in
GABBR2, only two were genotyped for the second time (i.e.,
rs2304389 and rs3750344). The SNPs for both genes were chosen
on the basis of minor allele frequency ($0.10) and to obtain
uniform physical coverage of the gene.
The SNPs for GABBR1 were genotyped using a TaqMan assay
in a 384-well microplate format, including four no-template
negative controls and four positive controls for each homozygous
genotype (12 total samples) (Applied Biosystems Inc., Foster City,
CA) as described previously [11,18]. Allelic discrimination was
performed on an ABI Prism 7900HT Sequence Detection System
(Applied Biosystems Inc., Foster City, CA). The GABBR2 SNPs
were genotyped using the Illumina BeadChip system at the Center
for Inherited Disease Research (CIDR) at Johns Hopkins
University.
Individual SNP and Haplotype Analysis
First, we used Haploview (v. 4.0) [20] to identify any
inconsistent Mendalian inheritance or other genotyping errors,
revealing about a 0.04% error rate for GABBR1 and 0.02% for
GABBR2. These samples were excluded from further data analysis.
Haploview (v. 4.0) was then used to assess linkage disequilibrium
(LD) and haplotype blocks for all SNPs included in this study.
Associations between individual SNPs and three ND measures
were determined using the Pedigree-Based Association Test
Table 1. Clinical characteristics of the African-American,
European-American, and pooled samples.
Characteristic
African-
Americans
European-
Americans Pooled
No. of nuclear families 402 200 602
Avg. members/family 3.1460.75 3.1760.69 3.1560.73
No. of subjects 1,366 671 2,037
Female (%) 66.1 69.5 67.2
Age (years) 39.4614.4 40.5615.5 39.7614.8
No. of smokers 1,053 515 1,568
Age of smoking onset 17.364.7 15.564.4 16.764.7
Years smoked 20.4612.5 23.2613.5 21.3612.9
Smoking quantity/day 19.4613.3 19.5613.4 19.5613.3
HSI 3.761.4 3.961.4 3.861.4
FTND score 6.2662.15 6.3362.22 6.2962.17
doi:10.1371/journal.pone.0007055.t001
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1.7.3) software was used to determine associations between
haplotypes and ND measures [22]. Haplotypes were determined
using a sliding-window approach, where three consecutive SNPs
were evaluated at once to determine the presence of any significant
three-SNP combinations. Three genetic models (i.e., additive,
dominant, and recessive) were tested for individual SNPs and
haplotypes with sex and age as covariates; ethnicity was an
additional covariate in the pooled sample, as all of these factors
affect ND [2]. Results statistically significant at the 0.05 level for
individual SNPs were determined by using a corrected P value of
0.002 for GABBR2 and a corrected P value of 0.008 for GABBR1
[23]. P values also were corrected for multiple testing of major
haplotypes (frequency $0.05), which differed by SNP combination
and sample grouping. We did not correct for three ND measure or
genetic models because of the concern that they are highly related.
Interaction Analysis of GABBR1 and GABBR2
Gene-by-gene interactions between SNPs in GABBR1 and
GABBR2 were analyzed using a newly developed PGMDR [24].
Selection of SNPs for interaction analysis for both genes was based
on their physical location: SNPs located in exons that encode each
functional domain of a subunit protein or SNPs within intronic
regions bordered by exons encoding the transmembrane or
cytoplasmic domain of each subunit. From GABBR2, we included
the following SNPs: rs585819, rs669095, rs6478676, and
rs13286336 on either side of exon 13, which encodes a
transmembrane protein domain; rs2304389 and rs10985765 in
exons 16 and 18, which encode two cytoplasmic protein domains,
and rs785648 and rs10818739 in introns 16 and 18. From
GABBR1, we included the following SNPs: rs29230 and rs29267 in
exon 16 that encodes a transmembrane domain and intron 16,
respectively, and rs2267633 in the 39-UTR and rs2267635 in
intron 6, which is bordered by exons that encode the extracellular
domain.
As with the previous association analyses, age and sex were
included as covariates for the EA and AA samples. Age, sex, and
ethnicity were included as covariates in the pooled sample. Gene-
by-gene interactions were examined for all two- to seven-locus
models. The top-ranked interaction model was chosen for a given
order of interaction, and its P value of prediction accuracy (PA)
was evaluated by a permutation test based on 1000 shuffles of the
adjusted phenotypic values. Because all P values reported here
were based on permutation tests of each interaction model, no
correction for multiple models is needed. For detailed information
on the PGMDR approach, please refer to the paper by Lou et al.
[24].
Results
Individual SNP Associations with ND for GABBR1 and
GABBR2
Table 2 shows allele frequencies (calculated by directly counting
the number of each progenitor allele) and P values for those SNPs
that showed significant associations with ND measures in at least
one sample before correction for multiple testing. In addition to
the seven GABBR2 SNPs identified in our previous report [11], 11
unique SNPs were significantly positively associated with ND in
the pooled sample (EA + AA; Table 2). However, the association
of individual SNPs varied as a function of ethnicity. That is, each
SNP identified as significant in the pooled sample was attributable
to either the AA or the EA sample, and there were no SNPs with
significant associations shared by the two ethnic groups.
Specifically, SNPs rs10120452, rs12337255, rs2900512, and
rs4743221 were associated with measures of ND in the AA
sample, whereas SNPs rs2779543, rs6478676, and rs7865648 were
associated with ND measures in the EA sample. Almost all SNPs
were marginally associated with ND measures except for
rs7865648 (P=0.0009), which remained significantly associated
with SQ in the EA sample after correction for multiple testing
(Table 2). For GABBR1, analysis revealed no significant association
with ND for any individual SNP in the three samples (data not
shown); rs29230 exhibited a trend with FTND in the pooled
sample (p=0.08).
Using the block definition proposed by Gabriel et al. [25], we
revealed eight blocks for GABBR2 in the pooled sample (Figure 1).
However, when LDs were assessed separately for each ethnic
group, there were slight differences in LD blocks at the 59 end of
Table 2. Allele frequencies and P values for association of individual GABBR2 SNPs with three measures of ND in pooled sample
and for each ethnic group*
{.
dbSNP ID (allele) Pooled sample AA sample EA sample
MAF SQ HSI FTND MAF SQ HSI FTND MAF SQ HSI FTND
rs1930135 (C/T) 0.43 0.09a 0.06a 0.04a 0.48 0.24a 0.15a 0.07a 0.30 0.11a 0.12r 0.23r
rs2779543 (G/A) 0.33 0.04r 0.03d,r 0.02a 0.38 0.12r 0.12r 0.06a 0.21 0.04d 0.02d 0.03d
rs10120452 (G/A) 0.26 0.008a 0.02a 0.01a 0.30 0.03a 0.05a 0.03a 0.17 0.07a 0.07a 0.07a
rs11788000 (T/C) 0.41 0.06a 0.06a 0.04a 0.44 0.18r 0.21r 0.08r 0.34 0.06a 0.05a 0.10a
rs12337255 (T/C) 0.16 0.07d 0.07d 0.04d 0.14 0.05d 0.03d 0.03d 0.23 0.46r 0.64r 0.73d,r
rs2900512 (C/T) 0.26 0.03d,r 0.01d,r 0.006d,r 0.28 0.06d 0.02d 0.01d,r 0.21 0.32d 0.26d 0.29d
rs7044793 (G/T) 0.36 0.03a 0.03d 0.03d,r 0.36 0.07a 0.09r 0.12r 0.37 0.24r 0.12a 0.10a
rs13295101 (T/C) 0.36 0.04a,d,r 0.03d,r 0.03d,r 0.36 0.08a 0.08r 0.11r 0.37 0.28r 0.16r 0.13r
rs4743221 (A/C) 0.28 0.06r 0.08r 0.02d,r 0.30 0.06r 0.04r 0.007d,r 0.23 0.81d 0.59r 0.56r
rs6478676 (G/A) 0.35 0.02d,r 0.03r 0.03r 0.32 0.22d 0.56d 0.40r 0.43 0.008d,r 0.006d,r 0.006d,r
rs7865648 (C/T) 0.34 0.006d 0.05r 0.04r 0.23 0.60r 0.89a 0.82d 0.37 0.0009r 0.01d,r 0.005r
*Corrected P value at the 0.05 significance level is 0.002.
{Values significant before correction are shown in bold. Values that survive correction are shown in bold italics.
a = additive model, d = dominant model, r = recessive model.
doi:10.1371/journal.pone.0007055.t002
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(Figure 2), and three blocks in the same region for EAs (Figure 3).
Specifically, a 34-kb block in EAs containing SNPs rs157927-
rs10512258-rs337526-rs337552 existed as two smaller blocks in
AAs (rs157927-rs10512258-rs337526, 24 kb, and rs337552-
rs509747, 11 kb).
Two blocks were identified in the pooled sample for GABBR1
(Figure 4A); however, when parsed into different ethnic groups,
the block structure became different in the two samples. The AA
sample had two blocks spanning the whole gene, with the first 4-kb
block containing rs2267633-rs29267 and a 17-kb block containing
rs29230-rs2267635-rs17184416 (Figure 4B). Conversely, the EA
sample had one 21-kb block consisting of SNPs rs2267633-
rs29267-rs29230-rs2267635 located at the 39 end of GABBR1
(Figure 4C).
Haplotype Associations with ND
Haplotype-based association analyses revealed several major
haplotypes that were significantly associated with ND for all
sample groups. After correction for multiple testing, there were 14
significant major haplotypes in GABBR2 in the pooled population
(Table 3), four in the AA population (Table 4), and five in the EA
population (Table 4). All the 14 haplotypes in the pooled sample
were located within intronic areas among exons that encode the
extracellular, transmembrane, and cytoplasmic domains, with
most of them residing among extracellular domain encoding exons
1–9. When the two ethnic groups were analyzed separately, the
haplotypes significantly associated with ND phenotypes differed
greatly in the AA and EA populations (Table 4). In AAs, all four
haplotypes that were significantly associated with FTND and one
or two heaviness of smoking measures (HSI and SQ) resided in the
intronic areas among extracellular domain-encoding exons
(Table 4A and Figure 5A). Conversely, in EAs, four of the five
significantly associated haplotypes were located in and around
cytoplasmic and transmembrane domain coding exons 16–19 and
10–15, respectively (Tables 4B, 4C and Figures 5B, 5C). Only one
haplotype located in the intronic areas among extracellular
domain encoding exons was significantly associated with SQ, but
not with FTND. Interestingly, the same three-SNP combination
(i.e., rs3750344-rs6478761-rs2900512) constituted a haplotype in
AAs with a differing allele combination, which was significantly
associated with FTND and also HSI: The A-A-T haplotype
(frequency 24.3%) was negatively associated with HSI (Z=22.88,
P=0.004) and FTND (Z=23.20, P=0.001) in AAs, whereas a G-
C-C haplotype (frequency 7.4%) was positively associated with SQ
(Z=2.68, P=0.007) in EAs. Thus, our results clearly indicate that
the significant haplotypes are ethnicity-specific, and the SNP loci
of these haplotypes are located in very different parts of the gene in
Figure 1. Linkage disequilibrium (LD) map of 33 SNPs within GABBR2 in pooled sample. Dark red denotes high LD (D9=1 and LOD .2).
Lower LD values are represented in shades of pink (0.21,D9,1 and LOD .2). White represents low LD and low LOD (LOD ,2). Numbers indicate the
D9 statistic for two consecutive SNPs. LD blocks were defined using Haploview [25].
doi:10.1371/journal.pone.0007055.g001
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direction of the effects of haplotypes was similar in the AA and EA
populations if we did not consider the significance of haplotype
effects, suggesting that even if the magnitude of their effects is a bit
different in the various backgrounds, the allelic basis of ND in both
groups is similar. In addition to the differences in haplotype
locations in the gene, the directions of haplotype effects on FTND
and heaviness of smoking (SQ and HSI) also differed in the two
ethnic groups. As shown in Table 4, in AAs, the haplotypes
significant under the recessive model were negatively associated
with FTND, SQ, and HSI, whilst the two significant haplotypes
under the dominant model were positively associated with FTND.
Interestingly, these directions were reversed in EAs; all the
significant haplotypes under the recessive model were positively
associated with FTND, SQ, and HSI, and the dominant haplotype
was negatively associated with SQ.
Haplotype analyses of GABBR1 revealed no major haplotypes
associated significantly with ND (data not shown). There were,
however, two minor haplotypes in the EA population (frequency
,5%) that were positively associated with HSI after correction for
multiple testing: rs2267635-rs29230-rs29267 (C-C-T; frequency
3.6%; Z=2.7, P=0.007) and rs29230-rs29267-rs2267633 (C-T-A;
frequency 3.8%; Z=2.7, P=0.007) (Table 5), both consisting of
SNP rs29230, a synonymous SNP in exon 16 encoding a
transmembrane domain protein. Although the SNPs selected for
this gene were targeted at the GABBR1 long isoform, these four
SNPs also exist in the short isoforms of GABBR1.
Interaction Analysis of GABBR1 and GABBR2
On the basis of the knowledge obtained from biochemical and
pharmacologicalstudies ofthe GABAB receptor,weinvestigatedthe
epistatic effect of SNPs from the transmembrane and cytoplasmic
domains of each GABAB subunit protein because interactions
among these domains have biological significance (Figure S1). That
is, these regions of the receptor proteins are involved in coupling of
the subunits for trafficking to the membrane and for pharmacolog-
ical activity. Our gene-by-gene interaction analysis revealed
significant epistatic effects between GABBR1 and GABBR2
(Table 6) on ND in the pooled and EA samples and also interactions
among SNPs within GABBR2 in all three samples (Table S1).
Three significant interactions were detected between SNPs in
GABBR1 and GABBR2. The same three-SNP combination was
detected for HSI and FTND (rs29230-rs7865648-rs585819;
P=0.001 and 0.005, respectively), and the addition of a fourth SNP
to this combination was detected for FTND (rs29230-rs7865648-
rs669095-rs585819; P=0.05). This four-SNP combination was
Figure 2. Linkage disequilibrium (LD) map of 33 SNPs within GABBR2 in African American, sample. Dark red denotes high LD (D9=1 and
LOD .2). Lower LD values are represented in shades of pink (0.21,D9,1 and LOD .2). White represents low LD and low LOD (LOD ,2). Numbers
indicate the D9 statistic for two consecutive SNPs. LD blocks were defined using Haploview [25].
doi:10.1371/journal.pone.0007055.g002
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other interactions were detected only in the pooled sample.
The majority of significant SNP interactions were seen within
GABBR2 for the pooled, EA, and AA samples (Table S1). Five
significant two- to four-SNP interactions were detected in the
pooled sample for SQ (rs10985765-rs7865648, P,0.001;
rs10985765-rs7865648-rs6478676, P=0.003; and rs10818739-
rs7865648-rs6478676-rs585819, P=0.004) and HSI (rs10985765-
rs13286336-rs669095-rs585819, P=0.05; and rs10985765-
rs7865648-rs6478676-rs669095, P=0.03). In the AA population,
one four-SNP combination, rs10985765-rs13286336-rs699095-
rs585819, was significantly associated with all three ND measures
(P=0.01–0.02). All other significant two- to four-SNP interactions
were identified in the EA sample: SQ and FTND: rs7865648-
rs585819, P,0.001; rs10985765-rs7865648-rs6478676-rs669095,
P=0.003; and 0.01; SQ alone: rs10818739-rs7865648-rs669095,
P,0.001 and HSI: rs10818739-rs585819, P=0.003; rs10818739-
rs6478676-rs585819, P,0.001; and rs10818739-rs7865648-
rs6478676-rs585819, P=0.03 (Table S1).
Discussion
The pharmacologically active GABAB receptors are formed by
heterodimerization of GABAB1 and GABAB2 subunit proteins
encoded by GABBR1 and GABBR2 genes, respectively. The
current study examined the association of GABBR1 and GABBR2
polymorphisms with ND individually and according to their
interactive effects in European-American and African-American
individuals.
First,ourfindingsrevealedasignificantassociationofheavinessof
smoking with SNP rs7865648 in EAs and significant associations of
ND with 14 major haplotypes in GABBR2 in the pooled sample,
after correction for multiple testing. When SNP data were analyzed
within each ethnic group, we found two protective and two risk
haplotypes unique to the AA sample and one protective and four
risk haplotypes unique to the EA sample. It was striking that these
unique loci were distributed in different regions of the gene in the
two races. Only one common SNP combination was significant in
the two ethnic samples but with a differing allelic haplotype in each
population, EAs possessing a risk haplotype (G-C-C) and AAs
having a protective haplotype (A-A-T). The five polymorphisms in
GABBR1 studied here showed no significant associations with any of
the ND measures; the smallest P value for association of rs29230
with FTND was 0.08 in the pooled sample. Haplotype analyses
revealed two minor haplotypes that were significantly associated
with HSI but not with FTND in the EA sample.
Second, in consideration of the fact that functional GABAB
receptors consist of both GABAB1 and GABAB2 subunits, we
Figure 3. Linkage disequilibrium (LD) map of 33 SNPs within GABBR2 in European American sample. Dark red denotes high LD (D9=1
and LOD .2). Lower LD values are represented in shades of pink (0.21,D9,1 and LOD .2). White represents low LD and low LOD (LOD ,2).
Numbers indicate the D9 statistic for two consecutive SNPs. LD blocks were defined using Haploview [25].
doi:10.1371/journal.pone.0007055.g003
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genes in affecting ND. Analyses using our newly developed
PGMDR method [24] demonstrated a significant interaction
between GABBR2 and GABBR1 polymorphisms, confirming
previous findings of pharmacological studies that showed GABAB
receptors function as heterodimers of GABAB1 and GABAB2
subunits. Together, our results provide first evidence for direct
association of ND with GABBR2 polymorphisms and an indirect
less significant association with GABBR1 polymorphisms.
Our current study has several unique strengths compared with
previous studies from our group and others that implicated loci on
chromosome 9, including the GABBR2 gene, in altering suscep-
tibility to ND [4,16]. On the basis of our early linkage findings, in
a previous study, we genotyped SNPs in GABBR2 and found that
seven of the 12 SNPs initially identified were significantly
associated with ND [11]. In consideration of the relatively scanty
coverage of GABBR2 and the small sample size in our earlier study,
we conducted the current study with the goal of extending our
previous results. In the previous study, 12 SNPs were genotyped in
about half of the participants of the current MSTF sample. Also,
we chose SNPs that provided complete coverage of the gene,
without consideration of previously genotyped SNPs. Thus, the
current study extends the previous findings by: (a) comprehensively
covering the gene by genotyping 33 SNPs for GABBR2, (b)
Figure 4. Linkage disequilibrium map of six SNPs within GABBR1 in pooled, African-American, and European-American samples.
Dark red denotes high linkage disequilibrium (LD) (D9=1 and LOD .2). Lower LD values are represented in shades of pink (0.21,D9,1 and LOD .2).
White represents low LD and low LOD (LOD ,2). Numbers indicate the D9 statistic for two consecutive SNPs. LD blocks were defined using Haploview
[25].
doi:10.1371/journal.pone.0007055.g004
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association analysis of GABBR1 with ND, and (d) examining the
interaction between GABBR1 and GABBR2.
The GABAB1 and GABAB2 subunits dimerize by coiling of C-
terminal domains of the two proteins following which the
subunits are transported to the plasma membrane, where the
receptor becomes pharmacologically active [26,27]. Further
evidence suggests the involvement of transmembrane domains in
the formation of heterodimers when the C-terminal domain is
truncated [28]. This is particularly interesting, considering that,
in EAs, haplotypes significantly associated with ND reside in the
introns among the transmembrane and cytoplasmic-domain-
encoding exons of GABBR2. Conversely, all haplotypes impli-
cated in ND of AAs reside in the introns among exons encoding
the binding domain of the GABBR2 subunit protein. The
function of the binding domain of GABAB2 is unclear, however,
as only GABAB1 is responsible for ligand binding in the
heterodimer configuration [29].T h e r e f o r e ,h a p l o t y p e st h a t
affect different portions of the GABAB heterodimer may have
functionally different consequences. For example, EAs may
possess GABAB2 subunits that are unable to dimerize with the
GABAB1 subunit, which consequently cannot traffic to the
membrane, resulting in fewer functional receptors. Conversely,
the affected GABAB2 binding domain has not been fully chara-
cterized, so it is difficult to speculate on the consequences of these
polymorphisms.
Although we found significant associations for GABBR2, but not
for GABBR1, with ND, significant interactions between these two
subunit genes were evident as reported here. Significant interac-
tions were detected between a synonymous SNP in the
transmembrane domain of GABBR1 and SNPs located in the
intronic regions among exons encoding transmembrane and
cytoplasmic domains of GABBR2. These statistical gene-by-gene
interactions are biologically relevant, as the subunits interact to
form a complete and functional receptor. Thus, the statistical
interaction most likely represents the functional properties of these
two subunits. Furthermore, we found that the majority of
significant interactions exist within the GABBR2 gene, suggesting
a stronger association of ND with GABBR2 polymorphisms
compared to associations of ND with both GABBR1 polymor-
phisms and GABBR1-by-GABBR2 interactive effects. However, it
should also be noted that the GABBR2 SNPs included in the
interaction models are located in the intronic regions among exons
encoding transmembrane and cytoplasmic domains of the
GABAB2 subunit. Therefore, these polymorphisms do not affect
the amino acid sequence of the transmembrane and cytoplasmic
subunits unless there is a strong linkage disequilibrium with
a causative variant in an exon; nevertheless, it is possible they affect
the structure of mature GABAB2 mRNA through alternate
splicing, resulting in altered GABAB2 protein subunits. Although
such a molecular mechanism is yet to be elaborated, the pre-
sence of six alternatively spliced mRNA variants for GABAB2
(http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/) streng-
thens the significance of functional SNPs in GABBR2 intronic
regions.
In sum, this study not only confirms our earlier finding that
GABBR2 is associated with ND but also demonstrates that an
interaction of GABBR1 and GABBR2 alters susceptibility to ND.
Our findings also indicated that GABBR2 represents a major
contributor to this phenomenon, and its biological and statistical
interaction with GABBR1 implies that the latter is indirectly
involved in ND. Furthermore, our results showed that the
Table 3. Haplotype frequencies, and Z- and P- values for association of three-SNP combinations in GABBR2 with three measures of
ND in the pooled sample*.
SNP Combination Haplotype % (# Families) Z value (P)
SQ HSI FTND
(A) Extracellular Domain:
rs1571927-rs1930135-rs2779543 A-T-A 28.8 (82) 22.40 (0.017)r 22.78 (0.006)r 22.77 (0.006)r
rs1930135-rs2779543-rs10120452 C-G-G 56.7(321.4) 2.16 (0.031)a 2.32 (0.020)a 2.52 (0.012)a
T-A-A 24.3 (56) 22.67 (0.023)r 22.60 (0.009)r 22.50 (0.012)r
rs2779543-rs10120452-rs11788000 G-G-T 57.7 (234.4) 2.27 (0.023)d 2.53 (0.011)d 2.77 (0.006)d
A-A-C 22.8 (267.4) 22.69 (0.007)a 22.63 (0.009)a 22.62 (0.009)a
rs10120452-rs11788000-rs2779536 G-T-A 59.1 (213.5) 2.26 (0.024)d 2.58 (0.010)d 2.84 (0.005)d
A-C-A 22.9 (264.2) 22.95 (0.003)a 22.68 (0.007)a 22.67 (0.008)a
rs3750344-rs6478761-rs2900512 A-A-T 22.9 (53) 22.38 (0.017)r 22.96 (0.003)r 23.18 (0.002)r
rs6478761-rs2900512-rs2808523 A-C-C 28.2 (220.3) 1.98 (0.047)d 2.38 (0.017)d 2.62 (0.009)d
A-T-C 18.6 (39) 23.26 (0.001)r 23.20 (0.001)r 23.17 (0.002)r
rs7044793-rs13295101-rs2779552 T-C-G 21 (246.4) 2.65 (0.008)a 2.09 (0.037)a 1.99 (0.047)a
rs1889983-rs4743221-rs7020345 A-A-A 58.3 (218) 2.29 (0.021)d 2.37 (0.018)d 2.87 (0.004)d
(B) Transmembrane Domain:
rs58519-rs669095-rs6478676 A-A-G 16.5 (21) 2.96 (0.003)r 2.48 (0.013)r 2.49 (0.013)r
(C) Cytoplasmic Domain:
rs2304389-rs7865648-rs10985765 C-T-T 33 (84) 2.65 (0.008)r 1.94 (0.053)r 1.90 (0.058)r
rs7865648-rs10985765-rs10818739 T-T-A 32.7 (83) 2.88 (0.004)r 2.16 (0.031)r 2.17 (0.030)r
*Values shown in bold are significant after correction for multiple testing of major haplotypes (i.e., haplotypes with a frequency .5%). Corrected P values differ by
population and haplotype. Models are the same as in Table 2.
doi:10.1371/journal.pone.0007055.t003
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PLoS ONE | www.plosone.org 9 September 2009 | Volume 4 | Issue 9 | e7055genetically determined vulnerability to ND is different in subjects
of European and African ancestry. These findings are further
supported by studies that demonstrated the regulation of receptor
expression after nicotine exposure in animal models, as well as the
impact on addictive behaviors in both animals and humans of the
GABAB agonist balcofen.
Table 5. Haplotype frequencies, and Z- and P-values for association of three-SNP combinations in GABBR1 with three measures of
ND in EA population*
{.
SNP Combination Haplotype % (# Families) Z-value (P)
SQ HSI FTND
rs2267635-rs29230- rs29267 C-T-T 8.3 (55) 21.30 (0.192)r 22.02 (0.044)r 22.07 (0.039)r
C-C-T 3.6 (22) 2.31 (0.020)a,d 2.72 (0.007)a,d 2.40 (0.017)a,d
rs29230- rs29267- rs2267633 T-T-A 8.4 (55) 21.30 (0.193)r 22.02 (0.044)r 22.07 (0.039)r
C-T-A 3.8 (22) 2.31 (0.021)a,d 2.72 (0.007)a,d 2.40 (0.017)a
*Values shown in bold are significant after correction for multiple testing of major haplotypes (i.e., haplotypes with a frequency .5%). Corrected P values differ by
population and haplotype. Models are the same as in Table 2.
{Note that significant haplotypes are minor haplotypes (i.e.,,5%).
doi:10.1371/journal.pone.0007055.t005
Figure 5. Physical location of detected significant major haplotypes on three functional domains of GABBR2. Vertical lines indicate
exons; horizontal lines indicate introns in GABBR2. Arrows signify the physical location of SNPs within each protein domain. The configuration of the
GABAB2 subunit protein is shown, containing numbers that correspond to the exons represented by vertical hash marks. Exons 1–9 are in the binding
domain, exons 10–15 are in the transmembrane domains, and exons 16–19 are in the cytoplasmic domain of the receptor protein. Significant
haplotypes are indicated for each sample group, including the Z score followed by P value and frequency in parentheses.
doi:10.1371/journal.pone.0007055.g005
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